Strive to Be Industry Leader in Search of Innovative Development Together! Lixin Ding Visited Leading Biopharmaceutical Enterprises

(Summary description)To further strengthen the support and speed up the cultivation of a group of leading biopharmaceutical enterprises with global influence, the Party Working Committee and Management Committee of the park carried out a comprehensive and detailed sorting of biopharmaceutical enterprises in the park and selected a group of leading enterprises with independent brands.

Categories:Media reports
Author:
Origin:
Time of issue:2020-02-28 16:18
Views:

Information

To further strengthen the support and speed up the cultivation of a group of leading biopharmaceutical enterprises with global influence, the Party Working Committee and Management Committee of the park carried out a comprehensive and detailed sorting of biopharmaceutical enterprises in the park and selected a group of leading enterprises with independent brands.

From February 26 to 27, Lixin Ding, deputy secretary of the Party Working Committee and director of the Management Committee of Suzhou Industrial Park, visited some of these enterprises in depth, and tailored the support plan to promote their further healthy and rapid growth and foster industry leaders in accordance with the principles of "one policy for one enterprise, precise policy implementation". Wenqing Xu, director of the Science and Technology Bureau of Suzhou Industrial Park, accompanied the visit.

Within a day and a half, Lixin Ding and his party successively visited Suzhou Kintor, Crystal Pharmatech, Yikon Genomics, CareRay Digital Medical System, TouchStone International Medical Science, and Hengrui Medicine. Where, Suzhou Kintor , Crystal Pharmatech, CareRay Digital Medical System and TouchStone International Medical Science are all enterprises proposing to be listed in 2020.